In a September 2020 article entitled, Understanding the hidden costs of COVID-19's potential impact on US healthcare by McKinsey states, "In the coming months, more deaths will undoubtedly occur as a direct result of the virus. However, there will likely be additional layers of delayed or indirect impact that result from deferred or canceled treatment, longer-term and unknown health impacts of those who recover from COVID-19, the physical and behavioral health impact of sheltering in place, and the tertiary health effects stemming from an economic downturn."
While the direct impact of COVID-19 has already been substantial, additional layers of delayed or indirect impact have the potential to dwarf the immediate effects.
These additional layers of impact related to COVID-19 could result in $125 billion to $200 billion in incremental annual US health system cost. Source: Global Management Consultants, McKinsey & Company, Sept. 2020.